Revenue
2018
2022
2023
2024
2025
DiaMedica Therapeutics Inc. (DMAC)
Price$6.69Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | $500,000 | — |
| Research & development | $24.6M | $19.1M | $13.1M | $7.8M | $8.8M | $8.2M | $7.9M | $4.5M | $3.2M |
| Operating expenses | $34.4M | $26.7M | $21.3M | $14.0M | $13.6M | $12.7M | $11.6M | $7.3M | $4.5M |
| Operating income | −$34.4M | −$26.7M | −$21.3M | −$14.0M | −$13.6M | −$12.7M | −$11.6M | −$6.8M | −$4.5M |
| Operating margin | — | — | — | — | — | — | — | −1,352.20% | — |
| EBITDA | −$34.4M | −$26.6M | −$21.2M | −$14.0M | −$13.6M | −$12.7M | −$11.6M | −$6.7M | −$4.5M |
| EBITDA margin | — | — | — | — | — | — | — | −1,349.20% | — |
| Net income | −$32.8M | −$24.4M | −$19.4M | −$13.7M | −$13.6M | −$12.3M | −$10.6M | −$5.7M | −$4.3M |
| Net profit margin | — | — | — | — | — | — | — | −1,146.80% | — |
| Basic EPSper basic share | -$0.70 | -$0.60 | -$0.60 | -$0.52 | -$0.65 | -$0.78 | -$0.89 | -$0.74 | -$0.72 |
| Diluted EPSper diluted share | -$0.70 | -$0.60 | -$0.60 | -$0.52 | -$0.65 | -$0.78 | -$0.89 | -$0.74 | -$0.72 |
Owners
Reported shareholders
≈16.37%of listed shares
TRILL AB / STAHLBERG JAN8.83M shares · Nov 25, 2025
View holders
| Holder | % owned |
|---|---|
TRILL AB / STAHLBERG JAN | ≈16.37%8.83M shares |
Von Koch Thomas / TomEnterprise AB / TomEnterprise Private AB | ≈15.55%8.38M shares |
JACINTO RICHARD II | ≈9.20%4.96M shares |
COOPERMAN LEON G | 6.40%3.45M shares |
BlackRock, Inc. | 4.18%2.25M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.66%894.12K shares |
MILLENNIUM MANAGEMENT LLC | 1.57%845.31K shares |
STATE STREET CORP | 1.20%646.74K shares |
Wambeke David J. | ≈0.98%527.11K shares |
Giuffre Randall Michael | ≈0.83%445.23K shares |
Bleichroeder LP | 0.71%382.32K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.66%355.52K shares |
OSAIC HOLDINGS, INC. | 0.63%338.11K shares |
NORTHERN TRUST CORP | 0.61%327.52K shares |
Pilnik Richard D. | ≈0.58%313K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.47%251.67K shares |
LPL Financial LLC | 0.43%233.5K shares |
VANGUARD FIDUCIARY TRUST CO | 0.38%207.44K shares |
GOLDMAN SACHS GROUP INC | 0.31%168.07K shares |
CITADEL ADVISORS LLC | 0.27%145.87K shares |
Percentages use 53.93M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 25, 2025Form 4 | TRILL AB +1TenPercentOwner | BuyCommon Shares · indirect | 73.1K | $8.57 | $626.5K | 8.83M |
| Nov 24, 2025Form 4 | TRILL AB +1TenPercentOwner | BuyCommon Shares · indirect | 40.3K | $7.89 | $317.6K | 8.75M |
| Nov 21, 2025Form 4 | TRILL AB +1TenPercentOwner | BuyCommon Shares · indirect | 208.9K | $7.41 | $1.55M | 8.71M |
| Nov 20, 2025Form 4 | TRILL AB +1TenPercentOwner | BuyCommon Shares · indirect | 128.4K | $7.41 | $951.6K | 8.50M |
| Nov 19, 2025Form 4 | TRILL AB +1TenPercentOwner | BuyCommon Shares · indirect | 240.4K | $7.21 | $1.73M | 8.38M |